Strategic Assessment of the Anxiety Disorders And Depression Treatment Market: Market Size, Share, Growth Projections
The global anxiety disorders and depression treatment market is expected to reach a value of USD 15.88 billion by 2030. The market is projected to grow at a CAGR of 3.6% from 2024 to 2030. The rising incidence of depression worldwide is anticipated to drive the market growth in the coming years. Increasing adoption of devices and psychotherapies has resulted in the declining demand for antidepressants in recent years.
Anxiety Disorders And Depression Treatment Market Report Highlights
- Presently, the antidepressant drugs segment holds the largest revenue share. However, due to the rising occurrence of adverse events associated with these therapeutics, this segment’s growth is expected to wane
- Patent expiration of branded medicines and the introduction of generic biosimilars, which are cost-effective, are responsible for the shrinking market of antidepressants
- On the other hand, the introduction of new medicines, such as Duloxetine, Fetzima, and Brintellix, is predicted to fuel the demand for therapeutics in the coming years
- Furthermore, the personalized therapies and devices segment is expected to register the fastest growth owing to its growing adoption by healthcare professionals as they exert fewer side effects as compared to drugs
- North American regional segment for anxiety disorders and depression treatment reached a saturation level owing to the availability of several medicines and the high prevalence of depressive disorders in this region
- The revenue captured by antidepressants is expected to decrease with generics dominating the market during the forecast period
For More Details or Sample Copy please visit link @: Anxiety Disorders And Depression Treatment Market Report
The rising geriatric population prone to depression and surging prevalence of anxiety disorders, including phobias and generalized anxiety disorder, are further contributing toward the growing demand for antidepressants to treat mental illnesses over the forecast period. Moreover, the introduction of technologically advanced therapies, such as medical implants used for brain stimulation and virtual reality exposure therapies using smartphone-based applications, furnish patients with innovative treatment alternatives.
List Of major companies in the Anxiety Disorders And Depression Treatment Market
- Pfizer Inc.
- Lundbeck A/S
- Glaxo SmithKline Pharmaceuticals Ltd.
- Merck & Co., Inc.
- Eli Lilly & Company
- AstraZeneca
- Bristol-Myers Squibb
- Johnson & Johnson
For Customized reports or Special Pricing please visit @: Anxiety Disorders And Depression Treatment Market Analysis Report
We have segmented the global anxiety disorders and depression treatment market by drugs, indication, distribution channel and region.
Research Methodology
We employ a comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecasts possible. We utilize a combination of bottom-up and top-down approaches for segmenting and estimating quantitative aspects of the market. Data is continuously filtered to ensure that only validated and authenticated sources are considered. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our market estimates and forecasts are derived through simulation models. A unique model is created and customized for each study. Gathered information for market dynamics, technology landscape, application development, and pricing trends are fed into the model and analyzed simultaneously.
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S. based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Contact:
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll-Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
#MentalHealth #AnxietyTreatment #DepressionCare #HealthcareInnovation #PsychiatricCare #MentalHealthSolutions #Wellness #TherapeuticAdvancements #BehavioralHealth #Pharmaceuticals #Psychology #MentalWellness #MentalHealthSupport #TherapyAndTreatment #MentalHealthMarket
Comments
Post a Comment